SAMSARA BIOCAPITAL, LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, SAMSARA BIOCAPITAL, LLC held in its portfolio 21 assets valued at $969,256,994 (i.e. $969.26M).

The most valuable assets in the portfolio included: SCHOLAR ROCK HLDG CORP ($303.84M), MINERALYS THERAPEUTICS INC ($213.06M), and KALARIS THERAPEUTICS INC ($109.28M).

The chart below shows the top 10 valuable assets, and the table below shows the top 21 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in SAMSARA BIOCAPITAL, LLC Portfolio

SCHOLAR ROCK HLDG CORP

MINERALYS THERAPEUTICS INC

KALARIS THERAPEUTICS INC

SEPTERNA INC

ALUMIS INC

NEUROGENE INC

INVENTIVA SA

GOSSAMER BIO INC

UPSTREAM BIO INC

AQUESTIVE THERAPEUTICS INC

SAMSARA BIOCAPITAL, LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
SCHOLAR ROCK HLDG CORP	6897652	303841571	COM
MINERALYS THERAPEUTICS INC	5871018	213059243	COM
KALARIS THERAPEUTICS INC	12948081	109281804	COM
SEPTERNA INC	3149128	87797689	COM
ALUMIS INC	5756984	56188164	COM
NEUROGENE INC	1717127	35372816	COM
INVENTIVA SA	5194805	24155843	ADS
GOSSAMER BIO INC	7222559	22389933	COM
UPSTREAM BIO INC	736047	19983676	COM
AQUESTIVE THERAPEUTICS INC	2500000	16150000	COM
JADE BIOSCIENCES INC	968798	14948553	COM NEW
VTV THERAPEUTICS INC	298496	11936855	CL A NEW
RANI THERAPEUTICS HLDGS INC	8500000	11475000	COM CL A
PALVELLA THERAPEUTICS INC NE	104817	10971195	COM
ABIVAX SA	75442	10173731	SPONSORED ADS
X4 PHARMACEUTICALS INC	1960000	7840000	COM NEW
NKARTA INC	3507666	6489182	COM
ARCELLX INC	60873	3968920	COMMON STOCK
SUTRO BIOPHARMA INC	204503	2366100	COM SHS
CONTINEUM THERAPEUTICS INC	72245	825760	CL A
NUVATION BIO INC	124119	40959	*W EXP 02/10/202